Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 48,024 | 22,592 | 59,005 | 44,806 | 26,371 |
| Depreciation Amortization | 940 | 468 | 1,554 | 1,087 | 703 |
| Income taxes - deferred | 7,184 | 4,523 | 13,002 | 9,864 | 5,637 |
| Accounts receivable | -7,896 | -7,630 | 26,130 | -10,018 | 9,814 |
| Accounts payable and accrued liabilities | 10,267 | 22,266 | 142 | 4,264 | 6,992 |
| Other Working Capital | 16,186 | 10,318 | 24,791 | -1,084 | -67 |
| Other Operating Activity | 22,689 | -2,338 | 13,361 | 35,172 | 964 |
| Operating Cash Flow | $97,394 | $50,199 | $137,985 | $84,091 | $50,414 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -104,672 | -31,755 | -187,425 | -117,244 | -55,160 |
| PPE Investments | -824 | -161 | -1,568 | -935 | -264 |
| Investing Cash Flow | $-105,496 | $-31,916 | $-188,993 | $-118,179 | $-55,424 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 23,967 | 6,389 | 40,753 | 32,177 | 15,925 |
| Other Financing Activity | -5,784 | -316 | -7,730 | -6,812 | -2,459 |
| Financing Cash Flow | $18,183 | $6,073 | $33,023 | $25,365 | $13,466 |
| Beginning Cash Position | 165,596 | 165,596 | 183,581 | 183,581 | 183,581 |
| End Cash Position | 175,677 | 189,952 | 165,596 | 174,858 | 192,037 |
| Net Cash Flow | $10,081 | $24,356 | $-17,985 | $-8,723 | $8,456 |
| Free Cash Flow | |||||
| Operating Cash Flow | 97,394 | 50,199 | 137,985 | 84,091 | 50,414 |
| Capital Expenditure | -824 | -161 | -1,568 | -935 | -264 |
| Free Cash Flow | 96,570 | 50,038 | 136,417 | 83,156 | 50,150 |